Investor's Business Daily on MSN
How BeOne Medicines, An IBD 50 Stock, Is Taking On Big Names In Cancer Treatment
As the former BeiGene gears up for an all-out war with AbbVieABBV, Johnson & JohnsonJNJ and AstraZenecaAZN, shares of the new BeOne MedicinesONC haven't been this high in four years.BeOne Medicines is ...
Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs ...
Hosted on MSN
Working Life: I know what it’s like to suffer with IBD, but I’ve turned a negative into a positive
“I was diagnosed with Crohn’s Disease at age 13. It started with a pain in my left knee and lower back. The GP put it down to a basketball injury. That Christmas, I ended up in the emergency ...
Over the last three years, the independent broker-dealer channel has seen the most consolidation in the wealth management industry. That's allowed the largest firms to control a significant amount of ...
Johnson & Johnson has launched its "Dual control" campaign in Asia Pacific, aiming to empower patients with inflammatory bowel disease (IBD) to manage their condition while pursuing life goals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback